It was found recently that A20 functions as a tumor suppressor in several subtypes of non-Hodgkin as well as Hodgkin lymphomas, and its silencing results in the constitutive activation of NF-κB [29],[87]. This evidence concerns the gene NFKB1 and Hodgkins lymphoma.